Nisa Investment Advisors
RIGL icon

Nisa Investment Advisors’s Rigel Pharmaceuticals RIGL Stock Holding History

Nisa Investment Advisors’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.9K Buy
303
+10
+3% +$308 ﹤0.01% 2419
2026
Q1 		$7.92K Hold
293
– – ﹤0.01% 2321
2025
Q4 		$12.5K Buy
293
+145
+98% +$5.47K ﹤0.01% 2131
2025
Q3 		$4.19K Hold
148
– – ﹤0.01% 2472
2025
Q2 		$2.77K Hold
148
– – ﹤0.01% 2542
2025
Q1 		$2.66K Hold
148
– – ﹤0.01% 2393
2024
Q4 		$2.49K Sell
148
-10
-6% -$192 ﹤0.01% 2421
2024
Q3 		$2.56K Sell
158
-147
-48% -$1.73K ﹤0.01% 2350
2024
Q2 		$2.51K Buy
305
+262
+609% +$2.74K ﹤0.01% 2353
2024
Q1 		$639 Buy
43
+29
+207% +$391 ﹤0.01% 2458
2023
Q4 		$196 Hold
14
– – ﹤0.01% 2560
2023
Q3 		$146 Sell
14
-2
-13% -$24 ﹤0.01% 2703
2023
Q2 		$210 Sell
16
-640
-98% -$8.65K ﹤0.01% 2698
2023
Q1 		$9K Buy
656
+640
+4,000% +$10.2K ﹤0.01% 2175
2022
Q4 		$0 Buy
+16
New +$147 ﹤0.01% 2692
2014
Q2 		– Sell
-1,460
Closed -$57K – 1325
2014
Q1 		$57K Buy
+1,460
New +$52K ﹤0.01% 1319

Other funds holding RIGL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nisa Investment Advisors's RIGL Position: Q2 2026 in Review

Nisa Investment Advisors increased its Rigel Pharmaceuticals (RIGL) stake by 3.4% in Q2 2026, buying an estimated $308 and bringing the position to 303 shares worth $11.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2419.

Nisa Investment Advisors first reported a position in RIGL in Q1 2014 and has held it in 16 quarters since. The position peaked at $57K in Q1 2014. 155 funds tracked by Wall St. Rank hold RIGL as of Q2 2026.

  • Nisa Investment Advisors held 303 shares of Rigel Pharmaceuticals worth $11.9K as of Q2 2026.
  • Nisa Investment Advisors bought 10 Rigel Pharmaceuticals shares in Q2 2026, an estimated $308.
  • Rigel Pharmaceuticals made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #2419 holding.
  • Nisa Investment Advisors first reported a position in Rigel Pharmaceuticals in Q1 2014 and has held it in 16 quarters since.
  • Nisa Investment Advisors's Rigel Pharmaceuticals position peaked at $57K in Q1 2014.
  • 155 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.